MedImmune, UCSF enter 3-year R&D deal

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 18 Feb, 2014

Singapore: MedImmune, the global biologics R&D arm of AstraZeneca, has entered into a three-year collaboration with ...Read more

Biogen to commercialize MS therapies in Asia

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 Feb, 2014

Singapore: Belgium based pharmaceutical company UCB and global pharmaceutical company, Biogen, have entered into an agre...Read more

BD launches Cell Analyzer to enhance drug discovery

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jul, 2013

Singapore: BD Biosciences, a global medical technology company, has launched BD LSRFortessa X-20 Cell Analyzer, to deliv...Read more

Viralytics melanoma study shows +ve results

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 25 Mar, 2013

Singapore: Assistant Professor (Dr) Robert H I Andtbacka presented a summary of his ongoing study with Viralytics' Cavat...Read more

India, EU firms fight 'epidemic of drug-resistance'

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 19 Apr, 2013

Singapore: India-based Orchid Pharma entered into a strategic partnership with Europe-based Allecra Therapeutics to deve...Read more

CoDa Therapeutics raises $19.8 mn from Russian firm

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Aug, 2012

Singapore: CoDa Therapeutics has raised an additional $19.8 million (NZ$24.5 million) from Russian investment firm Rusna...Read more

Chugai seeks nod for breast cancer drug in Japan

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 01 Feb, 2013

Singapore: Japanese multinational Chugai Pharmaceutical has filed a new drug application to the Ministry of Health, Labo...Read more

Viralytics presents +ve results of phase II Cavatak trial

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 19 Jul, 2013

Singapore: Viralytics reported strong interim results from its phase II clinical trial of Cavatak treatment in late stag...Read more

Competition intensifies for type 2 diabetes drugs

Drug Discovery |  Analysis | By BioSpectrum Bureau  | 1 Comment | 28 Aug, 2013

Singapore: The global pre-diabetes population is three times the size of the current diabetes patient population and the...Read more

FDA approval gives new hope to Multiple Sclerosis patients

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 13 Sep, 2012

Singapore: Genzyme, a Sanofi company, received approval from the US FDA for AUBAGIO (teriflunomide) as a new once-daily,...Read more

TaiGen files NDA for Nemonoxacin in Taiwan, China

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 16 May, 2013

Singapore: Taiwan's TaiGen Biotechnology has submitted New Drug Application (NDA) for the oral formulation of nemonoxaci...Read more

Verinata Health joins hands with Teva in Israel

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jul, 2013

Singapore: Illumina announced that Teva Pharmaceutical has signed an exclusive agreement with Verinata Health, an Illumi...Read more

Merck Serono starts Phase III non-small cell lung cancer drug trial

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 09 Apr, 2014

Singapore: Global biopharmaceutical firm Merck Serono has initiated international Phase III trial of its investigational...Read more

Pradaxa gets EU approval for DVT

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 10 Jun, 2014

Singapore: Boehringer Ingelheim has recieved Euroean approval for Pradaxa (dabigatran etexilate) for the treatment and p...Read more

AstraZeneca, LegoChem drug to curb superbugs

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 21 Dec, 2012

Singapore: AstraZeneca has formed collaboration with Korea's LegoChem Biosciences to develop a novel antibiotic to treat...Read more

Big pharma yet to warm up to drug resistance

Drug Discovery |  Analysis | By BioSpectrum Bureau  | 1 Comment | 01 Jun, 2012

Singapore: Drug resistance and patent expiries are demanding that the antibacterial drug market moves forward soon, but ...Read more

Cancer Therapeutics reveals new targeted drug

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 05 Jul, 2012

Singapore: Cancer Therapeutics, an Australian company focused on translating cancer biology research into novel treatmen...Read more

Eisai gets WHO prequalification, will donate 2.2 bn doses

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 03 Sep, 2013

Singapore: The WHO has prequalified Eisai's drug NTD002, a 100 mg tablet of diethylcarbamazine (DEC) for treatment of el...Read more